Disclosures for "Optimizing Periprocedural Antiplatelet Therapy: Clinical Outcomes Of Intravenous Versus Oral P2y12 Inhibitors In Neurovascular and Cardiovascular Interventions"
Dr. Julius has nothing to disclose.
Mr. Naqvi has nothing to disclose.